Many thanks ...been a shareholder for about 7 months now . Was in the Pharma industry during the first 16 years of my career and quite frankly, have not seen a drug that has so much potential as Leronlimab. I’ve learned over the years with companies like Cytodyn is to focus in on the deliverables and timing rather than the stock price. I understand it’s difficult to watch the price lately but I’m focused on 6 potential positive outcomes in the next six weeks which would help build the foundation for this company for years to come..ima patient investor